Credit inquiries fall into two categories: soft credit checks and hard credit checks. They're triggered by different events ...
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
Google has unveiled new generative AI features for its mapping and geospatial apps that are designed with enterprise users in mind. The new features, announced at Cloud Next in Las Vegas this week, ...
Ibogaine is a plant-derived psychedelic medication that is illegal in the U.S. and many other countries. It causes hallucinations that can last more than 24 hours and cause cardiac problems. Studies ...
Forbes contributors publish independent expert analyses and insights. Lucy Paulise is executive coach and author of Timebox, based in Texas. Employee engagement, commitment or motivation to success ...
A new, stronger flu shot could slash Alzheimer’s risk in half, according to new data. The study, led by researchers at the University of Texas Health Science Center at Houston (UTHealth), found that ...
If you’ve been struggling with your mental health lately, a new free service could help. Medicare Mental Health Check In launched earlier this year to give more Australians access to mental health ...
CLEVELAND — National Doctors' Day is a chance to say thank you — but this year, the conversation goes much deeper than gratitude. Across Northeast Ohio and the country, patients and physicians are ...
A state official warned the CEO of a background check firm that he could face criminal charges for not having a private investigator's license. The warning came after the arrest of Des Moines Public ...
Wondering how early to get to the airport as some TSA officers call out sick during a partial government shutdown? There are a few ways for passengers to check security checkpoint wait times before ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results